PP_1170x120_10-25-21

molnupiravir

FDA authorizes Merck pill for COVID-19 treatment

FDA authorizes Merck pill for COVID-19 treatment

WASHINGTON — The Food and Drug Administration on Thursday authorized Merck’s COVID-19 pill for certain adults. The authorization for molnupiravir is limited to adults over 18 who have a high risk of severe illness and “for whom alternative FDA-authorized treatment options are not accessible or medically appropriate,” the FDA said in a press release Thursday.

NACDS: Pharmacists may be able to treat COVID

NACDS: Pharmacists may be able to treat COVID

ARLINGTON, Va. — Pharmacists may be able to “initiate treatment” of COVID-19 with pills like molnupiravir if the medications get emergency use authorization (EUA), an official with the National Association of Chain Drug Stores said Wednesday. “The story isn’t over,” Sara Roszak, NACDS’ senior vice president of health and wellness strategy and policy, said at

White House spends $1 billion to boost COVID testing

White House spends $1 billion to boost COVID testing

NEW YORK — In an effort to keep reining in the pandemic, the Biden administration will invest $1 billion to quadruple the national supply of at-home COVID-19 tests by December. In addition, it is expanding the number of free community-based test sites to 30,000 nationwide, including 20,000 in pharmacies. The White House’s announcement of the

Adheris Health